A randomized, controlled, multi-center, safety and efficacy study of FCR001 cell-based therapy relative to a tacrolimus and mycophenolate-based regimen in de novo living donor renal transplant recipients, and safety in FCR001 donors Grant uri icon

Overview

date/time interval

  • July 1, 2020 - June 30, 2024

sponsor award ID

  • TT 203563-01

Affiliation